Arbutus Biopharma Corporation (ABUS) dipped -9.87% or -0.51 to $4.66. It is approximately 226829 shares traded, which is 38.45% compare to the average total volume 589898. The market cap of ABUS is $258.18 million. The year to date change is -15.0%. The 52 week price range is from $4.01 to $12.6. Price of ABUS have changed 21.36% during last week. It have changed -46.48% over last month, -56.37% over last 3 months, -7.68% over last 6 months and -4.26% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ABUS is 7.67. It is 64.59% above current price. The 200-day Moving Averages for ABUS is 7.00. It is 50.21% above current price. The 52-week High is 12.6. It is 170.39% from the current price. The 52-week Low is 4.01. It is -13.95% from current price.
There are some statistics of ABUS. It is has market cap $258.18 million. The share outstanding is 55.40 million. The average volume is 589898. The revenue is 6.89M. The gross profit is -8645000. The percent of top 15 Institution holding is 89.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ABUS is -46.19%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ABUS is -25.43%.